Those who were not tested for a BRCA1/2mut were significantly older than those who were tested (66.7 vs. 58.0 years; p < 0.001) and significantly less likely to be employed (11% vs. 26%; p < 0.001), be premenopausal (3% vs. 15%; p < 0.001), have a family history of BRCA1/2-related cancer (10% vs. 28%; p < 0.001), have TNBC (4% vs. 22%; p < 0.001), or be tested in an academic setting (52% vs. 61%; p < 0.001). This evidence concerns the gene BRCA1 and cancer.